Risk factors for cefotaxime resistance in children with pneumonia
Background Pneumonia is a health problem in developing countries, often caused by bacterial agents. The 'Widespread use of cefotaxime, a thirdgeneration of cephalosporin, may lead to increased incidence of resistance to this antibiotic. Several studies have reported on risk factors associated...
Saved in:
Main Authors: | Anak Agung Made Sucipta (Author), Ida Bagus Subanada (Author), Samik Wahab (Author) |
---|---|
Format: | Book |
Published: |
Indonesian Pediatric Society Publishing House,
2012-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical predictors of hypoxemia in 1-5 year old children with pneumonia
by: Made Supartha, et al.
Published: (2016) -
Piperacillin/tazobactum and cefotaxime decrease the effect of beta lactamase production in multi-drug resistant K. pneumoniae
by: Chackaravarthi Gnanasekaran, et al.
Published: (2021) -
Economic Evaluation of the Use of Cefotaxime and Ceftazidime in the Treatment of Pneumonia in Pediatric Patients
by: Valen Ruterlin, et al.
Published: (2017) -
Pneumonia Atipikal
by: Budastra I Nyoman, et al.
Published: (2016) -
Rifaximin plus cefotaxime versus cefotaxime alone in treatment of spontaneous bacterial peritonitis in patients with cirrhosis
by: Asmaa N Mohammad, et al.
Published: (2018)